Literature DB >> 27798969

The Influence of Body Mass Index on Outcomes in Ureteroscopy: Results from the Clinical Research Office of Endourological Society URS Global Study.

Amy Krambeck1, Nienke Wijnstok2, Peter Olbert3, George Mitroi4, Simon Bariol5, Hemendra N Shah6, Ahmed S El-Abd7, Bulent Onal8, Jean de la Rosette2.   

Abstract

INTRODUCTION: Although ureteroscopy (URS) has been established as a viable treatment for stones in obese patients, its safety and success has not been fully elucidated. The current study describes the worldwide prevalence of obesity in patients with urolithiasis and examines trends in URS outcomes, safety, and efficacy.
METHODS: This study utilized the Clinical Research Office of the Endourological Society (CROES) URS Global Study, which was a prospective, multicenter study including 11,885 patients treated with URS for urinary stones at 1 of 114 urology departments across 32 countries. The relationship between body mass index (BMI), diabetes, and creatinine, with retreatment, stone-free rates, complications, and long hospital stay, was examined with a multivariate logistic regression analyses.
RESULTS: Of the 10,099 URS patients with BMI data, 17.4% were obese and 2.2% were super obese. Overall, 86.7% patients were stone free and 16.8% required retreatment. Higher BMI was associated with lower stone-free rates, and any deviation from normal weight was associated with higher retreatment rates. In multivariate analysis controlling for several variables including stone size, the association between BMI and lower stone-free rates with higher retreatment rates persisted. Intraoperative complications occurred in 518 (5.1%) patients, and 343 (3.4%) experienced a postoperative complication. Postoperative complications were more frequent in the underweight and super obese subjects, and there was no relationship between BMI and intraoperative complications. DISCUSSION: Although URS for stone disease was found to be an overall safe procedure for obese and super obese patients, efficacy of the procedure may be lower compared with normal-weight subjects and higher retreatment rates may be necessary.

Entities:  

Keywords:  BMI; URS; obesity; stone disease

Mesh:

Year:  2016        PMID: 27798969     DOI: 10.1089/end.2016.0514

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Ureteroscopy Is Equally Efficient and Safe in Obese and Morbidly Obese Patients: A Systematic Review and Meta-Analysis.

Authors:  Wei Wang; XiaoShuai Gao; Liao Peng; Tao Jin
Journal:  Front Surg       Date:  2022-02-18

2.  Can We Identify Patients in Danger of Complications in Retrograde Intrarenal Surgery?-A Retrospective Risk Factors Analysis.

Authors:  Jakub Marek Ratajczak; Taras Hladun; Bartosz Krenz; Krzysztof Bromber; Maciej Salagierski; Michał Marczak
Journal:  Int J Environ Res Public Health       Date:  2022-01-20       Impact factor: 3.390

Review 3.  Ureteroscopy for stone disease: expanding roles in the modern era.

Authors:  Adrian Ho; Piyush Sarmah; Ewa Bres-Niewada; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2017-06-11

4.  Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content.

Authors:  Arman Tsaturyan; Elizaveta Bokova; Piet Bosshard; Olivier Bonny; Daniel G Fuster; Beat Roth
Journal:  Urolithiasis       Date:  2020-08-07       Impact factor: 3.436

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.